Rimegepant trials for Migraine

All Rimegepant trials · All Migraine trials

Phase breakdown

Recruiting trials studying Rimegepant for Migraine

• A Comparison of Nurtec ODT to Maxalt MLT-ODT in Adult ED Patients With Migraine Headache
  NCT06473597 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant in Adults With Migraine
  NCT07609914 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 14 locations
• A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
  NCT06641466 · Phase: Phase 3 · Ages: 18 Years to 45 Years · Sex: Female · 123 locations
• Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
  NCT05156398 · Phase: Phase 3 · Ages: 6 Years to 17 Years · Sex: All (male and female) · 93 locations
• Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant
  NCT05046613 · Phase: Not specified · Ages: 0 Years and older · Sex: Female · 1 location

Common questions

How many trials study Rimegepant for Migraine?

5 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.